Head of Roche Venture Nuechterlein to depart 

Carole Nuechterlein will move on from Roche Venture Fund next spring after 25 years with the VC. A search for a new head of the fund has begun.

Arima Genomics Inc. has a new CEO to go with a freshly raised $22 million series C round. Tom Willis spent a decade at Illumina Ventures, which led the round, and was founder and CEO of Parallele Bioscience Inc. and Sequenta Inc. Earlier in his career, he directed technology development at the Stanford Genome Technology Center during the Human Genome Project. Founder and former CEO Sid Selvaraj becomes president and COO of the cancer diagnostics company. ...